DE60116662D1 - Hemmung von systemischen infektionen in menschen und wirbeltieren mit ballaststoffen - Google Patents

Hemmung von systemischen infektionen in menschen und wirbeltieren mit ballaststoffen

Info

Publication number
DE60116662D1
DE60116662D1 DE60116662T DE60116662T DE60116662D1 DE 60116662 D1 DE60116662 D1 DE 60116662D1 DE 60116662 T DE60116662 T DE 60116662T DE 60116662 T DE60116662 T DE 60116662T DE 60116662 D1 DE60116662 D1 DE 60116662D1
Authority
DE
Germany
Prior art keywords
inhibition
systemic infections
dietary fiber
ballasts
swiveling
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60116662T
Other languages
English (en)
Other versions
DE60116662T2 (de
Inventor
K Buddington
Loo Jan Van
Anne Frippiat
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Tiense Suikerraffinaderij NV
Mississippi State University
Original Assignee
Tiense Suikerraffinaderij NV
Mississippi State University
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24693153&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DE60116662(D1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Tiense Suikerraffinaderij NV, Mississippi State University filed Critical Tiense Suikerraffinaderij NV
Publication of DE60116662D1 publication Critical patent/DE60116662D1/de
Application granted granted Critical
Publication of DE60116662T2 publication Critical patent/DE60116662T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/20Reducing nutritive value; Dietetic products with reduced nutritive value
    • A23L33/21Addition of substantially indigestible substances, e.g. dietary fibres
    • A23L33/22Comminuted fibrous parts of plants, e.g. bagasse or pulp
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23VINDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00Food compositions, function of food ingredients or processes for food or foodstuffs

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Food Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Nutrition Science (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Molecular Biology (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Fodder In General (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DE60116662T 2000-09-28 2001-09-27 Hemmung von systemischen infektionen in menschen und wirbeltieren mit ballaststoffen Expired - Lifetime DE60116662T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US671106 2000-09-28
US09/671,106 US7431939B1 (en) 2000-09-28 2000-09-28 Inhibition of systemic infections in humans and vertebrates by dietary fibers
PCT/EP2001/011198 WO2002026242A2 (en) 2000-09-28 2001-09-27 Inhibition of systemic infections in humans and vertebrates by dietary fibers

Publications (2)

Publication Number Publication Date
DE60116662D1 true DE60116662D1 (de) 2006-04-06
DE60116662T2 DE60116662T2 (de) 2006-11-09

Family

ID=24693153

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60116662T Expired - Lifetime DE60116662T2 (de) 2000-09-28 2001-09-27 Hemmung von systemischen infektionen in menschen und wirbeltieren mit ballaststoffen

Country Status (11)

Country Link
US (1) US7431939B1 (de)
EP (1) EP1320375B1 (de)
JP (1) JP4309650B2 (de)
CN (1) CN1315482C (de)
AT (1) ATE315399T1 (de)
CA (1) CA2423783C (de)
DE (1) DE60116662T2 (de)
DK (1) DK1320375T3 (de)
ES (1) ES2252317T3 (de)
NO (1) NO331751B1 (de)
WO (1) WO2002026242A2 (de)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7431939B1 (en) 2000-09-28 2008-10-07 Mississippi State University Inhibition of systemic infections in humans and vertebrates by dietary fibers
US20040001898A1 (en) * 2002-06-26 2004-01-01 Armand Malnoe Compositions and methods for detoxification and cancer prevention
US8143235B2 (en) 2005-12-16 2012-03-27 N.V. Nutricia Use of dietary fibres against muscle wasting
AU2007245002B2 (en) * 2006-03-29 2012-05-03 Société des Produits Nestlé S.A. Dietary supplements containing probiotics
US20090061008A1 (en) * 2007-08-30 2009-03-05 Levy Mark M Fiber/granule complex for treatment of the gi tract
DK2285387T3 (en) 2008-06-13 2016-01-25 Nutricia Nv Nutrition for preventing infections
MX2012015235A (es) * 2010-06-30 2013-02-15 Oreal El uso de ácido cicórico y derivados en complemento alimenticio para regular la pigmentación de la piel.
CN104244940B (zh) 2012-02-16 2018-07-20 阿克索生物医药公司 减少胃肠道的弯曲杆菌定植
WO2013187755A1 (en) 2012-06-14 2013-12-19 N.V. Nutricia Fermented infant formula with non digestible oligosaccharides
ES2966909T3 (es) 2014-08-13 2024-04-25 Akeso Biomedical Inc Compuestos y composiciones antimicrobianos, y usos de los mismos
CN104872457A (zh) * 2015-06-23 2015-09-02 通威股份有限公司 一种提高罗非鱼抗链球菌能力的配合饲料
AU2016102452A4 (en) * 2015-06-23 2020-12-24 Société des Produits Nestlé S.A. Nutritional compositions and infant formulas containing oligofructose for reducing the load of pathogenic bacteria in the guts of infants and young children
ES2760351T3 (es) * 2015-08-04 2020-05-13 Suedzucker Ag Utilización profiláctica de inulina contra la sinusitis
DK3334440T3 (en) 2015-08-11 2021-07-26 Akeso Biomedical Inc Biofilm inhibiting compositions enhancing weight gain in livestock
US10653658B2 (en) 2015-08-11 2020-05-19 Akeso Biomedical, Inc. Biofilm inhibiting compositions enhancing weight gain in livestock
CN105124248A (zh) * 2015-08-28 2015-12-09 通威股份有限公司 一种提高红罗非鱼抗病机能的配合饲料
EP3207933A1 (de) * 2016-02-17 2017-08-23 Proponent Biotech GmbH Verwendungen von polyfructanen
BE1025705B1 (fr) * 2017-09-12 2019-06-18 Cosucra Groupe Warcoing Sa Amélioration de la maladie et des conditions générales de la volaille et du bétail à l'aide d'une racine chicorée séchée
US10842811B2 (en) * 2018-02-28 2020-11-24 The Trustees Of Columbia University In The City Of New York Inulin for preventing antibiotic resistant infection and pathogen colonization

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH0725683B2 (ja) * 1985-10-31 1995-03-22 ザ オ−ストラリアン ナシヨナル ユニバ−シテイ− 免疫治療方法
US5032579A (en) 1987-10-13 1991-07-16 Coors Biotech, Inc. Method for inhibiting the growth of salmonella
AU651626B2 (en) 1990-10-24 1994-07-28 Nestec S.A. Medical foods having soluble fiber
ES2060543B1 (es) * 1993-03-26 1995-04-01 Cia Gral Del Algarrobo De Espa Fibra natural de algarroba y procedimiento para su obtencion.
EP0638589B1 (de) 1993-08-10 1998-01-28 Südzucker Aktiengesellschaft Mannheim/Ochsenfurt Verfahren zur Herstellung von Inulinderivaten
WO1995018608A1 (en) 1994-01-11 1995-07-13 N.V. Nutricia Method of treating disorders of the animal or human body by administering amino acids
US6241983B1 (en) * 1994-10-28 2001-06-05 Metagenics, Inc. Bacteria-and fiber-containing composition for human gastrointestinal health
US5531989A (en) 1994-10-28 1996-07-02 Metagenics, Inc. Immunoglobulin and fiber-containing composition for human gastrointestinal health
DE69506095T2 (de) * 1995-08-04 1999-06-24 Nutricia Nv Diätfasern enthaltende Nahrungszusammensetzung
EP0879600A1 (de) * 1997-05-20 1998-11-25 Tiense Suikerraffinaderij N.V. (Raffinerie Tirlemontoise S.A.) Fruktan-haltige Zusammensetzung zur Vorbeugung und Behandlung von Dickdarmkrebs
DK0887024T3 (da) 1997-06-23 2004-09-27 Nestle Sa Ernæringssammensætning omfattende ærtefibre og inulin
EP0904784A1 (de) 1997-09-22 1999-03-31 N.V. Nutricia Probiotisches Ernährungspräparat
US6248375B1 (en) * 2000-03-14 2001-06-19 Abbott Laboratories Diabetic nutritionals and method of using
US7431939B1 (en) 2000-09-28 2008-10-07 Mississippi State University Inhibition of systemic infections in humans and vertebrates by dietary fibers
EP1428528A1 (de) 2002-09-27 2004-06-16 Tiense Suikerraffinaderij N.V. Synergistische Zusammensetzungen aus Ballaststoffe und NSAID zur Behandlung von Krebs

Also Published As

Publication number Publication date
NO331751B1 (no) 2012-03-19
WO2002026242A2 (en) 2002-04-04
US7431939B1 (en) 2008-10-07
ATE315399T1 (de) 2006-02-15
WO2002026242A3 (en) 2002-05-30
EP1320375A2 (de) 2003-06-25
CA2423783A1 (en) 2002-04-04
NO20031259D0 (no) 2003-03-19
JP2004509922A (ja) 2004-04-02
CN1315482C (zh) 2007-05-16
NO20031259L (no) 2003-05-07
DK1320375T3 (da) 2006-05-22
CN1466460A (zh) 2004-01-07
ES2252317T3 (es) 2006-05-16
DE60116662T2 (de) 2006-11-09
EP1320375B1 (de) 2006-01-11
CA2423783C (en) 2007-11-20
JP4309650B2 (ja) 2009-08-05

Similar Documents

Publication Publication Date Title
DE60116662D1 (de) Hemmung von systemischen infektionen in menschen und wirbeltieren mit ballaststoffen
BR9706897A (pt) Composições antifúngicas com biodisponibilidade aperfeiçoada.
RO116342B1 (ro) Compoziţie farmaceutică lichidă, orală
LU90987I2 (fr) Copaxone et ses dérivés pharmaceutiquement acceptables
BG101781A (en) Active substance-containing solid preparation
BG103862A (en) Compositions of derivatives of erythromycin with continuous release
ATE147264T1 (de) Peroral applizierbare arzneiform zur behandlung zentraler dopaminmangelzustände
AR098808A2 (es) Una forma de dosificación farmacéutica de fusión instantánea que se desintegrará en la boca en un tiempo de 25 segundos
KR920702216A (ko) 아세틸 d-카르니틴의 녹내장 치료에의 용도
HUP0003323A2 (hu) Vorikonazolt tartalmazó gyógyászati készítmények
CY1105908T1 (el) Στοματικως αποσαθρουμενα δισκια που πepιλαμβανουν βενζιμιδαζολιο
HUP9802356A2 (hu) Foggondozó táplálék hobbi állatoknak
SE9800550D0 (sv) A pharmaceutical preparation comprising an angiotensin II type 2 receptor agonist, and use thereof
TR200100629T2 (tr) Mide-bağırsak aktif maddeleri içeren mukozaya yapışan oral bileşimler
JP2004509922A5 (de)
CA2120062A1 (en) Use of Sulodexide and of Medicines Containing It in the Treatment of Diabetic Nephropathy
MY119090A (en) Synthetic polysaccharides, process for their preparation and pharmaceutical compositions containing them
ATE289803T1 (de) Pharmazeutische aerosolformulierung
AU2002210436A1 (en) Medical technical product, method for producing the same and providing the same for surgery
FI955837A0 (fi) Menetelmä suun kautta annettavan, kiinteän, diklofenaakkia sisältävän annostelumuodon valmistamiseksi
DE69126183D1 (de) LPS-produzierende Bakterien, Lipopolysiccharide und LPS enthaltende Arzneimittel und tierärztliche Medikamente
GEP20043254B (en) Use of Camptothecin Derivatives with Reduced Gastrointestinal Toxicity
KR910016327A (ko) 호중구에 의한 엘라스타제 방출 저해제로서의 테니댑의 용도
KR960003718A (ko) 말초신경병 및 중추신경변성병의 치료에 유용한 의약의 제조를 위한 이펜프로딜 및 그 부분입체이성질체의 이용
AU2001295839A1 (en) Use of agents active against candida in the treatment of disorders of the oral and intestinal mucosa

Legal Events

Date Code Title Description
8363 Opposition against the patent